PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   


Catalogue
Number
Product Order number / Unit

9712 DOTA-NOC acetate 9712.0001: 1 mg per vial
9712.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.

 
Precursor for radiolabelled DOTA-NOC
Ligand for somatostatin receptors
Molar Mass: 1455.7
C69H94N14O17S2
[619300-53-7] (net peptide)
Colourless to off-white freeze-dried solid packaged in screw cap vials.
Purity: ≥ 95 %
Certificates:
CoA; MS (identity); HPLC (purity)
Chemical Name:
Sequence: DOTA-D-Phe-Cys-Nal-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide Cys2,7
DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-
Nal = 3-(1-naphthalenyl )-L-alanyl
Supplied as acetate salt
Synonymes:
DOTA-[Nal3]-octreotide; CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)- L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Literature:
Wild D. et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur.J. Nucl. Med. Mol. Imaging 2005, 32, 724.
Wild D. et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1338-1347.
date of product catalogue issue: 10 May 2017

 
 
 

  PDF file       product list       home page       search       email       legal notice